A Multiple-dose Study in Chinese Subjects to Evaluate Safety,Tolerability,PK and PD of ZM-H1505R

Clinical trial NCT05470829 · COMPLETED

Trial details

NCT number: NCT05470829
Sponsor: Shanghai Zhimeng Biopharma, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Hepatitis B, Chronic

Start date: 2021-05-27
Primary completion: 2021-11-17
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.